Ceren Tilgen Yasasever

Clinical significance of serum interleukin-18 (IL-18) levels in patients with gastric cancer

Faruk Taş, Ceren Tilgen Yasasever, Senem Karabulut et al. · Biomedicine & Pharmacotherapy · 2015 · 34 citations

Inflammation, Gastrointestinal Oncology, Medicine +7

Circulating annexin A2 as a biomarker in gastric cancer patients: Correlation with clinical variables

Faruk Taş, Ceren Tilgen Yasasever, Senem Karabulut et al. · Biomedicine & Pharmacotherapy · 2014 · 28 citations

Prognostic Biomarkers, Medicine, Annexin A2 +8

High serum transforming growth factor beta 1 (TGFB1) level predicts better survival in breast cancer

Rümeysa Çiftçi, Faruk Taş, Ceren Tilgen Yasasever et al. · Tumor Biology · 2014 · 24 citations

Serum transforming growth factor-beta 1 (TGF-β1) levels have diagnostic, predictive, and possible prognostic roles in patients with melanoma

Faruk Taş, Senem Karabulut, Ceren Tilgen Yasasever et al. · Tumor Biology · 2014 · 22 citations

The diagnostic, predictive, and prognostic role of serum epithelial cell adhesion molecule (EpCAM) and vascular cell adhesion molecule-1 (VCAM-1) levels in breast cancer

Senem Karabulut, Faruk Taş, Didem Taştekin et al. · Tumor Biology · 2014 · 21 citations